SEC Form 4 · accession 0001144204-17-045035
BIOHITECH GLOBAL, INC. · BHTG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank E. Celli
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Aug 11, 2017
Accepted (ET)
Aug 24, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590383
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF3,F1,F2 | $3.00 | Aug 11, 2017 | S | 1 | A | May 24, 2017 | May 24, 2018 | Common Stock | 63,333 | 1 | D |
| WarrantsF5,F4 | $3.75 | Aug 11, 2017 | S | 31,667 | A | May 24, 2017 | May 24, 2022 | Common Stock | 31,667 | 31,667 | D |
Explanation of responses
- F1Represents the highest possible conversion price.
- F2Represents the number of shares of common stock, par value $$0.0001 per share ("Common Stock") into which the note is convertible based on the conversion price of $3.00 per share. The note is convertible into an indeterminable number of shares.
- F3Does not include 1,293,685 shares of Common Stock held by the reporting person; 819,303 shares of Common Stock underlying convertible debentures and promissory notes or warrants to purchase and additional 745,303 shares of Common Stock held by the reporting person.
- F4Represents the highest possible exercise price of the warrant. The warrants are exercisable into an indeterminable number of shares.
- F5Represents the number of shares of Common Stock into which the warrants are exercisable based on the exercise price of $3.75 per share.